Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 39 (HNRNPA1P39)

Target
HNRNPA1P39
Molecular classification
Other, Pseudogene
01

Overview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 39 (HNRNPA1P39) is a processed pseudogene and a non-protein-coding sequence related to the parent HNRNPA1 gene. Pseudogenes like HNRNPA1P39 do not encode functional proteins due to accumulated mutations. While some pseudogenes have emerging regulatory roles in gene expression by acting as competitive endogenous RNAs or as sources of regulatory noncoding RNAs, there is currently no specific functional or disease association described for HNRNPA1P39 itself in available genomic databases or scientific literature. Key context: - Pseudogenes, by definition, lack the ability to encode a functional product due to mutations or truncations. - The parental protein (hnRNPA1) *is* an RNA-binding protein with important roles in mRNA splicing, gene expression, and is implicated in neurodegenerative diseases and cancer. However, these functions are *not* attributable to HNRNPA1P39. - Current gene and protein databases (GeneCards, BioGPS, Merck Millipore) confirm HNRNPA1P39 is annotated as a pseudogene only, with no demonstrated protein product or therapeutic relevance. In summary: HNRNPA1P39 is not a canonical therapeutic drug target, has no direct biological or clinical function established, and may be listed in research databases for genomic and regulatory studies rather than target identification or drug development.

02

Mechanism of action

None

03

Biological functions

May participate as a non-coding RNA or competitive endogenous RNA, but no direct molecular function as a protein
04

Disease associations

No direct disease roles as a protein; potential indirect regulatory roles via RNA in gene regulation and cancer (general for pseudogenes, not specifically established for HNRNPA1P39)

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 39 (HNRNPA1P39).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 39 (HNRNPA1P39).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call